Adial Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Adial Pharmaceuticals, Inc. (ADIL) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 18.59 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-28
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 20.76M shares, a 44.41% increase year-over-year.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 19.85M shares, a 45.45% increase year-over-year.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 17.59M shares, a 55.76% increase year-over-year.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 15.91M shares, a 51.58% increase year-over-year.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 18.59M shares, a 49.15% increase from fiscal 2020.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 12.46M shares, a 26.50% increase from fiscal 2019.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 9.85M shares, a 107.01% increase from fiscal 2018.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 4.76M shares, a 45.80% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 20.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 20.30M shares derived: average of 2 quarters · filed 2022-03-28 | 19.40M shares derived: average of 3 quarters · filed 2022-03-28 | 18.59M shares 10-K · filed 2022-03-28 |
| 2021-09-30 | 19.85M shares 10-Q · filed 2021-11-15 | 18.72M shares derived: average of 2 quarters · filed 2021-11-15 | 17.86M shares 10-Q · filed 2021-11-15 | 16.93M shares derived: average of 4 quarters · filed 2022-03-28 |
| 2021-06-30 | 17.59M shares 10-Q · filed 2021-08-12 | 16.85M shares 10-Q · filed 2021-08-12 | 15.96M shares derived: average of 3 quarters · filed 2022-03-28 | 15.38M shares derived: average of 4 quarters · filed 2022-03-28 |
| 2021-03-31 | 15.91M shares 10-Q · filed 2021-05-17 | 15.14M shares derived: average of 2 quarters · filed 2022-03-28 | 14.65M shares derived: average of 3 quarters · filed 2022-03-28 | 13.81M shares derived: average of 4 quarters · filed 2022-03-28 |
| 2020-12-31 | 14.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 14.01M shares derived: average of 2 quarters · filed 2022-03-28 | 13.11M shares derived: average of 3 quarters · filed 2022-03-28 | 12.46M shares 10-K · filed 2022-03-28 |
| 2020-09-30 | 13.65M shares 10-Q · filed 2021-11-15 | 12.47M shares derived: average of 2 quarters · filed 2021-11-15 | 11.83M shares 10-Q · filed 2021-11-15 | 11.51M shares derived: average of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | 11.29M shares 10-Q · filed 2021-08-12 | 10.89M shares 10-Q · filed 2021-08-12 | 10.80M shares derived: average of 3 quarters · filed 2021-08-12 | 10.66M shares derived: average of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | 10.50M shares 10-Q · filed 2021-05-17 | 10.55M shares derived: average of 2 quarters · filed 2021-05-17 | 10.45M shares derived: average of 3 quarters · filed 2021-05-17 | 10.40M shares derived: average of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | 10.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | 10.43M shares derived: average of 2 quarters · filed 2021-03-22 | 10.36M shares derived: average of 3 quarters · filed 2021-03-22 | 9.85M shares 10-K · filed 2021-03-22 |
| 2019-09-30 | 10.25M shares 10-Q · filed 2020-11-13 | 10.24M shares derived: average of 2 quarters · filed 2020-11-13 | 9.60M shares 10-Q · filed 2020-11-13 | 8.84M shares derived: average of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | 10.22M shares 10-Q · filed 2020-08-13 | 9.24M shares 10-Q · filed 2020-08-13 | 8.37M shares derived: average of 3 quarters · filed 2020-08-13 | 7.67M shares derived: average of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | 8.25M shares 10-Q · filed 2020-05-14 | 7.45M shares derived: average of 2 quarters · filed 2020-05-14 | 6.81M shares derived: average of 3 quarters · filed 2020-05-14 | 6.00M shares derived: average of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | 6.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | 6.09M shares derived: average of 2 quarters · filed 2020-03-20 | 5.25M shares derived: average of 3 quarters · filed 2020-03-20 | 4.76M shares 10-K · filed 2020-03-20 |
| 2018-09-30 | 5.55M shares 10-Q · filed 2019-11-14 | 4.55M shares derived: average of 2 quarters · filed 2019-11-14 | 4.13M shares 10-Q · filed 2019-11-14 | 3.91M shares derived: average of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | 3.56M shares 10-Q · filed 2018-09-10 | 3.41M shares 10-Q · filed 2019-08-13 | 3.36M shares derived: average of 3 quarters · filed 2019-08-13 | 3.34M shares derived: average of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | 3.27M shares 10-Q · filed 2019-05-13 | 3.26M shares derived: average of 2 quarters · filed 2019-05-13 | 3.26M shares derived: average of 3 quarters · filed 2019-05-13 | 3.26M shares derived: average of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | 3.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | 3.26M shares derived: average of 2 quarters · filed 2019-02-19 | 3.26M shares derived: average of 3 quarters · filed 2019-02-19 | 3.26M shares 10-K · filed 2019-02-19 |
| 2017-09-30 | 3.27M shares 10-Q · filed 2018-11-14 | 3.27M shares derived: average of 2 quarters · filed 2018-11-14 | 3.27M shares 10-Q · filed 2018-11-14 | |
| 2017-06-30 | 3.27M shares 10-Q · filed 2018-09-10 | 3.26M shares 10-Q · filed 2018-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |